High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer

Michele L. Donato, David M. Gershenson, James T. Wharton, Cindy M. Ippoliti, Ana S. Aleman, Diane Bodurka-Bevers, Michael W. Bevers, Thomas W. Burke, Charles F. Levenback, Judith K. Wolf, Ralph S. Freedman, Robert C. Bast, James L. Gajewski, Richard E. Champlin

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences